MABS460-I

Anti-FGF23 Antibody, clone 278-2

• UNSPSC-Code: 12352203
• NACRES: NA.41

Eigenschaften

• Biologische Quelle: human
• Qualitätsniveau: 200
• Konjugat: unconjugated
• Antikörperform: purified antibody
• Antikörper-Produkttyp: primary antibodies
• Klon: 278-2, monoclonal
• Mol-Gew.: calculated mol wt 27.95 kDa; observed mol wt ~37 kDa
• Aufgereinigt durch: using protein G
• Speziesreaktivität: human
• Verpackung: antibody small pack of 100 μg
• Methode(n): flow cytometry: suitable; western blot: suitable
• Isotyp: IgG1κ
• Epitopsequenz: Unknown
• Protein-ID-Hinterlegungsnummer: NP_065689
• UniProt-Hinterlegungsnummer: Q9GZV9
• Versandbedingung: 2-8°C
• Posttranslationale Modifikation Target: unmodified
• Angaben zum Gen: human ... fgf23> FGF23(8074)

Beschreibung

Allgemeine Beschreibung

Fibroblast growth factor 23 (UniProt: Q9GZV9; also known as FGF-23, Phosphatonin, Tumor-derived hypophosphatemia-inducing factor) is encoded by the FGF23 (also known as HYPF, UNQ3027/PRO9828) gene (Gene ID: 8074) in human. FGF23 is a growth factor that is produced primarily in the bone tissue and its primary hormonal function is to regulate phosphate homeostasis and vitamin D metabolism. Unlike other FGFs, it has a low affinity for heparin sulfate, which allows it to enter the circulation and act as an endocrine hormone. It inhibits renal tubular phosphate transport by reducing sodium-dependent phosphate transport protein 2A (SLC34A1) levels. FGF23 binding to FGFR requires a co‐receptor, Klotho, which acts as a scaffold for docking with FGFR1. Together with Klotho, it modulates phosphate reabsorption and both 1 ‐hydroxylation and 24‐hydroxylation in the renal proximal tubules. FGF23 is reported to inhibit the expression of 1 ‐hydroxylase while increasing the expression of 24‐hydroxylase, thus reducing the concentration of active 1,25(OH)2D. It can also act directly on the parathyroid to reduce parathyroid hormone secretion. (Ref.: Almel, EA., et al. (2019). J. Bone Min. Res (JMBR Plus). 3(8): e10190).

Spezifität

Clone 278.2 is a mouse monoclonal antibody that detects human Fibroblast growth factor 23 (FGF-23).

Immunogen

Recombinant human Fibroblast growth factor 23 (FGF23).

Anwendung

Quality Control Testing

Evaluated by Western Blotting in Human brain tissue lysates.

Western Blotting Analysis: A 1:1,000 dilution of this antibody detected FGF23 in Human brain tissue lysates.

Tested Applications:

Flow Cytometry Analysis (FC): 1 μg of this antibody detected Fibroblast growth factor 23 (FGF23) in one million Jurkat cells pretreated with Brefeldin A (1 μg/mL 4 h).

Anti-FGF23, clone 278-2, Cat. No. MABS460-I, is a mouse monoclonal antibody that detects Fibroblast growth factor 23 and is tested for use in Flow Cytometry and Western Blotting.

Physikalische Form

Purified mouse monoclonal antibody IgG1 in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.

Lagerung und Haltbarkeit

Recommend storage at +2°C to +8°C. For long term storage antibodies can be kept at -20°C. Avoid repeated freeze-thaws.

Sonstige Hinweise

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Haftungsausschluss

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Sicherheitshinweise

• Lagerklassenschlüssel: 12 - Non Combustible Liquids
• WGK: WGK 1
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable